肿瘤科

订阅

MedSci主页 / 所有栏目 / 肿瘤科

CSCO 2014：绝经后激素受体阳性乳腺癌高危人群风险控制

2014-09-18 廖莉莉 医学论坛网

乳腺癌
关注

  乳腺癌内分泌治疗论坛(1楼1F-1会议室)时间:9月20日10:50~11:20         报告者:北京大学人民医院王殊 乳腺癌是女性最常见的恶性肿瘤,我国虽属乳腺癌相对低发地区,但发病率逐年上升。据北京市肿瘤防治研究办公室数据显示,2012年北京市乳腺癌新增4311例,发病率高达

  乳腺癌内分泌治疗论坛(1楼1F-1会议室)时间:9月20日10:50~11:20

        报告者:北京大学人民医院王殊

乳腺癌是女性最常见的恶性肿瘤,我国虽属乳腺癌相对低发地区,但发病率逐年上升。据北京市肿瘤防治研究办公室数据显示,2012年北京市乳腺癌新增4311例,发病率高达64.63例/10万人,成为女性发病率最高的恶性肿瘤。

乳腺癌的发病风险随年龄增加而升高,其中约75%的患者为激素受体[ER和(或)PR]阳性,此类患者的总生存率和无复发生存率均明显优于激素受体(ER和PR)阴性患者,但仍需面对局部复发和远处转移风险。

系统治疗是降低患者复发转移风险的有效手段,在激素受体阳性患者中,内分泌治疗的地位已非常明确。绝经后激素受体阳性乳腺癌患者高危人群风险控制可选择他莫昔芬或第三代芳香化酶抑制剂(AI)。

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1984208, encodeId=cec31984208f1, content=<a href='/topic/show?id=5445e889395' target=_blank style='color:#2F92EE;'>#绝经后激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78893, encryptionId=5445e889395, topicName=绝经后激素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f4467, createdName=AspirantSuo, createdTime=Mon Jan 26 11:33:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980831, encodeId=497d19808314c, content=<a href='/topic/show?id=aaf6668192d' target=_blank style='color:#2F92EE;'>#激素受体阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66819, encryptionId=aaf6668192d, topicName=激素受体阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Fri Mar 20 05:33:00 CST 2015, time=2015-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675022, encodeId=e56316e502264, content=<a href='/topic/show?id=7d321022504e' target=_blank style='color:#2F92EE;'>#高危人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102250, encryptionId=7d321022504e, topicName=高危人群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e95727161035, createdName=Smile2689, createdTime=Sat Apr 18 19:33:00 CST 2015, time=2015-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257006, encodeId=5e18125e0066c, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sat Sep 20 04:33:00 CST 2014, time=2014-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631486, encodeId=04d416314867b, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78883, encryptionId=6395e888343, topicName=绝经后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32b921798518, createdName=zxxiang, createdTime=Sat Sep 20 04:33:00 CST 2014, time=2014-09-20, status=1, ipAttribution=)]
    2015-01-26 AspirantSuo

    #绝经后激素#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1984208, encodeId=cec31984208f1, content=<a href='/topic/show?id=5445e889395' target=_blank style='color:#2F92EE;'>#绝经后激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78893, encryptionId=5445e889395, topicName=绝经后激素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f4467, createdName=AspirantSuo, createdTime=Mon Jan 26 11:33:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980831, encodeId=497d19808314c, content=<a href='/topic/show?id=aaf6668192d' target=_blank style='color:#2F92EE;'>#激素受体阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66819, encryptionId=aaf6668192d, topicName=激素受体阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Fri Mar 20 05:33:00 CST 2015, time=2015-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675022, encodeId=e56316e502264, content=<a href='/topic/show?id=7d321022504e' target=_blank style='color:#2F92EE;'>#高危人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102250, encryptionId=7d321022504e, topicName=高危人群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e95727161035, createdName=Smile2689, createdTime=Sat Apr 18 19:33:00 CST 2015, time=2015-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257006, encodeId=5e18125e0066c, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sat Sep 20 04:33:00 CST 2014, time=2014-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631486, encodeId=04d416314867b, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78883, encryptionId=6395e888343, topicName=绝经后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32b921798518, createdName=zxxiang, createdTime=Sat Sep 20 04:33:00 CST 2014, time=2014-09-20, status=1, ipAttribution=)]
    2015-03-20 mjldent

    #激素受体阳性#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1984208, encodeId=cec31984208f1, content=<a href='/topic/show?id=5445e889395' target=_blank style='color:#2F92EE;'>#绝经后激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78893, encryptionId=5445e889395, topicName=绝经后激素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f4467, createdName=AspirantSuo, createdTime=Mon Jan 26 11:33:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980831, encodeId=497d19808314c, content=<a href='/topic/show?id=aaf6668192d' target=_blank style='color:#2F92EE;'>#激素受体阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66819, encryptionId=aaf6668192d, topicName=激素受体阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Fri Mar 20 05:33:00 CST 2015, time=2015-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675022, encodeId=e56316e502264, content=<a href='/topic/show?id=7d321022504e' target=_blank style='color:#2F92EE;'>#高危人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102250, encryptionId=7d321022504e, topicName=高危人群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e95727161035, createdName=Smile2689, createdTime=Sat Apr 18 19:33:00 CST 2015, time=2015-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257006, encodeId=5e18125e0066c, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sat Sep 20 04:33:00 CST 2014, time=2014-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631486, encodeId=04d416314867b, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78883, encryptionId=6395e888343, topicName=绝经后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32b921798518, createdName=zxxiang, createdTime=Sat Sep 20 04:33:00 CST 2014, time=2014-09-20, status=1, ipAttribution=)]
    2015-04-18 Smile2689

    #高危人群#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1984208, encodeId=cec31984208f1, content=<a href='/topic/show?id=5445e889395' target=_blank style='color:#2F92EE;'>#绝经后激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78893, encryptionId=5445e889395, topicName=绝经后激素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f4467, createdName=AspirantSuo, createdTime=Mon Jan 26 11:33:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980831, encodeId=497d19808314c, content=<a href='/topic/show?id=aaf6668192d' target=_blank style='color:#2F92EE;'>#激素受体阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66819, encryptionId=aaf6668192d, topicName=激素受体阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Fri Mar 20 05:33:00 CST 2015, time=2015-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675022, encodeId=e56316e502264, content=<a href='/topic/show?id=7d321022504e' target=_blank style='color:#2F92EE;'>#高危人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102250, encryptionId=7d321022504e, topicName=高危人群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e95727161035, createdName=Smile2689, createdTime=Sat Apr 18 19:33:00 CST 2015, time=2015-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257006, encodeId=5e18125e0066c, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sat Sep 20 04:33:00 CST 2014, time=2014-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631486, encodeId=04d416314867b, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78883, encryptionId=6395e888343, topicName=绝经后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32b921798518, createdName=zxxiang, createdTime=Sat Sep 20 04:33:00 CST 2014, time=2014-09-20, status=1, ipAttribution=)]
    2014-09-20 yeye5224612

    #绝经#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1984208, encodeId=cec31984208f1, content=<a href='/topic/show?id=5445e889395' target=_blank style='color:#2F92EE;'>#绝经后激素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78893, encryptionId=5445e889395, topicName=绝经后激素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f4467, createdName=AspirantSuo, createdTime=Mon Jan 26 11:33:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980831, encodeId=497d19808314c, content=<a href='/topic/show?id=aaf6668192d' target=_blank style='color:#2F92EE;'>#激素受体阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66819, encryptionId=aaf6668192d, topicName=激素受体阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Fri Mar 20 05:33:00 CST 2015, time=2015-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675022, encodeId=e56316e502264, content=<a href='/topic/show?id=7d321022504e' target=_blank style='color:#2F92EE;'>#高危人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102250, encryptionId=7d321022504e, topicName=高危人群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e95727161035, createdName=Smile2689, createdTime=Sat Apr 18 19:33:00 CST 2015, time=2015-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257006, encodeId=5e18125e0066c, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sat Sep 20 04:33:00 CST 2014, time=2014-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631486, encodeId=04d416314867b, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78883, encryptionId=6395e888343, topicName=绝经后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32b921798518, createdName=zxxiang, createdTime=Sat Sep 20 04:33:00 CST 2014, time=2014-09-20, status=1, ipAttribution=)]
    2014-09-20 zxxiang

    #绝经后#

    0

相关资讯

JCEM：肠道菌群多样性高的个体乳腺癌风险低

近日，来自美国国家癌症研究所的研究人员通过研究表示，绝经后女性如果机体中携带有多样化的肠道菌群，那么其机体的雌激素代谢产物或许对其健康更加有益，相关研究刊登于国际杂志Journal of Clinical Endocrinology &Metabolism （JCEM）上。 从20世纪70年代开始，科学家们就通过研究发现，构成肠道微生物组的肠道细菌会影响女性机体雌激素的功能，雌激素是

新型“电子皮肤”可进行乳腺癌早期筛查

Nat Genet：与东亚女性乳腺癌有关的3种基因

在线发表于《自然—遗传学》上的一项研究报告了影响东亚女性乳腺癌的3种遗传变化。这项研究结果为这类人群的乳腺癌遗传学研究提供了新见解。 大多数乳腺癌研究聚焦的研究对象是具有欧洲血统的女性。Qiuyin Cai等人研究了超过22000位患有乳腺癌的东亚女性，确定了数个可导致乳腺癌发生的针对亚洲的特定遗传变化。 他们找到靠近3种基因——ARRDC3、 PRC1和ZC3H11A的D

JNCI：豆浆并非人人都能喝

大豆已经成为很多国家的主要主粮，但大豆中富含植物雌激素，人在食用这些豆制类食物后，这些激素就会在体内模拟雌激素，过多食用可能会导致体内激素紊乱，而如果患有相关疾病如乳腺癌，则可能会进一步加重乳腺癌患病情况。尽管一些研究显示亚洲人的摄取大豆的比例在增加，乳腺癌的发生率却在下降，然而这并不能证实大豆对这些病患很友善。日前，一项对已经发生乳腺癌的女性进行研究发现，食用大豆能加重乳腺癌患者的患病情况。相关

2014年ASCO 乳腺癌治疗主要研究进展

作者：中国医学科学院肿瘤医院   徐兵河  王佳玉2014年美国临床肿瘤学会(ASCO)上，乳腺癌的临床研究再次成为亮点之一，许多临床研究结果都在这次会议上进行了报道，本文对其中几项最重要的临床治疗研究进展介绍如下。1、绝经前受体阳性早期乳腺癌的辅助内分泌治疗1.1  比较依西美坦/他莫昔芬联合卵巢功能抑制治疗绝经前HR+早期乳腺癌的随机III期研究:&

CSCO 2014： 一场“纵横交错”的学术盛宴

作为乳腺癌">乳腺癌、脑转移癌、循环肿瘤细胞 (CTC)、mTOR抑制剂专场的负责人,我们 在各个专场的设计中颇下了番“功夫”。这 些设置也比较契合今年 CSCO 年会的主题 ——“提升规范水平,拓展国际视野”,既注 意通过继续教育提升规范化水平,又要顾及大家对于学术前沿内容的需求。 规范·纵深系统地呈现乳腺癌的多&nb